All Remaking R&D articles

Article How AI and Decentralized Clinical Trials are Changing Biopharma
March 3, 2022 | By Scott Kirsner
“As humans, we have limitations in being able to integrate and synthesize and look at data,” says venture capitalist John Orloff, formerly Global Head of R&D at Alexion Pharmaceuticals. “I think AI and machine learning technology will allow us to make better decisions and choices, and give us new insights...
On Demand Webcast Converting Ideas into Realized Value at Cisco
February 24, 2022
In this Master Class, Artem Ignatenko and Tad Haas discuss Cisco’s journey of establishing an “assembly line for innovation delivery,” creating one seamless and holistic process for converting successful ideas into business value.
Article Kellogg’s R&D Chief on Plant-Based Proteins and New Ways of Testing Products
February 22, 2022 | By Scott Kirsner
The company’s SVP of Global R&D talks about getting plant-based protein to an affordable price point; how the company is moving from focus groups to in-market testing; and why the $13 billion company hires “food designers” rather than food scientists.
Article Comcast Labs SVP on Trends, Working with Startups, and Failing Fast
February 19, 2022
Comcast SVP Ruth Dawson lays out the trends she’s paying attention to, and the three avenues that a Comcast Labs project can travel: a hand-off to the business, a temporary hold, or a full stop.
Article How W.L. Gore Looks to Partnerships, R&D, and Acquisitions to Accelerate Progress
February 19, 2022
The privately-held company’s Chief Technology Officer, Greg Hannon, talks about metrics, AI, and healthcare as a growth industry.
Article Hain Celestial SVP on Creating a Unified R&D Team at ‘Hain 3.0’
February 19, 2022
The VP of Corporate Research talks about building innovation while simultaneously reinventing business models.